TriSalus Life Sciences TLSI
NASDAQ TLSI
$4.34 +0.19 (+4.65%)
As of: Oct 2, 2026 · 10:20 AM EDT

TriSalus Life Sciences (TLSI) Liabilities and Shareholders Equity (2020 - 2026)

Updated

TriSalus Life Sciences' Liabilities and Shareholders Equity was $62.45 million in Q2 2026, up 51.1% from $41.32 million a year earlier but down 12.0% from the prior quarter.

Analysis

TriSalus Life Sciences (TLSI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at TriSalus Life Sciences came in at $35.33 million, up 47.4% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -32.5% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $23.97 million in FY2024 (-2.5%), $24.6 million in FY2023 (+11.8%), $22 million in FY2022 (-91.2%) and $250.53 million in FY2021 (-0.6%).
  • Quarterly Liabilities and Shareholders Equity has moved between $12.24 million (Q2 2023) and $251.33 million (Q3 2022) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for six straight quarters, with growth averaging 43.2% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q2 2024 (growth of 165.0%); the worst was Q2 2023 (a decline of 95.1%).
  • Per Business Quant data, TLSI's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $70.98 million (Q1 2026), $35.33 million (Q4 2025) and $36.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 TriSalus Life Sciences 264.93 Mn 118.97 Mn 9.90 Mn 62.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.45 Mn
Mar 31, 2026 70.98 Mn
Dec 31, 2025 35.33 Mn
Sep 30, 2025 36.46 Mn
Jun 30, 2025 41.32 Mn
Mar 31, 2025 28.63 Mn
Dec 31, 2024 23.97 Mn
Sep 30, 2024 27.48 Mn
Jun 30, 2024 32.43 Mn
Mar 31, 2024 17.89 Mn
Dec 31, 2023 24.60 Mn
Sep 30, 2023 33.55 Mn
Jun 30, 2023 12.24 Mn
Mar 31, 2023 20.52 Mn
Dec 31, 2022 22.00 Mn
Sep 30, 2022 251.33 Mn
Jun 30, 2022 250.55 Mn
Mar 31, 2022 250.40 Mn
Dec 31, 2021 250.53 Mn
Sep 30, 2021 250.76 Mn
API Access

TriSalus Life Sciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TLSI&period=max&api_key=YOUR_API_KEY